Malignant Pharyngeal Neoplasm — Trials

Malignant Pharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 222
Ph III recruiting: 64
Growth YoY: +6.1%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 101–150 of 532 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05524168	SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma	active not recruiting	Phase 2	41	Sun Yat-sen UniversityOTHER	1	May 7, 2026	clinicaltrials
NCT03848286	KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma	completed	Phase 2	153	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.INDUSTRY	1	May 5, 2026	clinicaltrials